mizoribine has been researched along with Glomerulonephritis, Membranous in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Fukushima, S; Iwano, M; Kasuno, K; Kimura, H; Kobayashi, M; Mikami, D; Morita, S; Naiki, H; Nishikawa, S; Nishikawa, Y; Nishimori, K; Sakashita, S; Shimamoto, Y; Takahashi, N; Yokoi, S | 1 |
| Chang, W; Sun, N; Wang, X; Zhang, M | 1 |
| Chang, W; Han, Y; Liu, Y; Wang, X; Zhang, M; Zhang, W | 1 |
| Manabe, S; Nagata, M; Nitta, K | 1 |
| Matsumoto, Y; Moriki, T; Nojima, Y; Shimada, Y | 1 |
| Fujimoto, S; Makino, H; Maruyama, S; Matsuo, S; Mori, N; Narita, I; Nishio, S; Okuda, S; Saito, T; Sato, H; Sugiyama, H; Ueda, Y; Yamagata, K; Yokoyama, H; Yuzawa, Y | 1 |
| Hanada, K; Ito, T; Mochizuki, K; Oka, T; Tanabe, K | 1 |
| An, W; Liu, Y; Song, X; Tu, Y; Wang, X; Zhang, W | 1 |
| Fujita, A; Kawakami, T; Kimura, K; Shirai, S; Soma, Y | 1 |
| Fujita, T; Fuke, Y; Ito, K; Matsumoto, K; Satomura, A; Shimizu, C | 1 |
| Akimoto, T; Higashizawa, T; Inoue, M; Isoda, N; Kusano, E; Muto, S; Nishino, K; Otake, T; Saito, O; Sugano, K; Takahashi, H; Tanaka, A | 1 |
| Yumura, W | 1 |
| Kurokawa, K; Mitarai, T; Nishi, S; Saito, T; Sakai, H; Shiiki, H; Yokoyama, H; Yorioka, N; Yoshimura, A | 1 |
| Arakawa, M; Harada, T; Hishida, A; Ishida, M; Ishikawa, I; Kashihara, N; Kobayashi, Y; Koike, T; Koyama, A; Maeda, K; Makino, H; Mitarai, T; Muso, E; Nagasawa, T; Nagase, M; Nojima, Y; Osawa, G; Saito, T; Sakai, O; Sato, H; Sato, M; Shibasaki, T; Shiiki, H; Sugisaki, T; Tomino, Y; Tomita, K; Yamabe, H; Yorioka, N | 1 |
| Harada, T; Horita, Y; Kohno, S; Miyazaki, M; Nishioka, Y; Suyama, N; Tadokoro, M; Taura, K | 1 |
| Amano, I; Matsumoto, Y | 1 |
3 review(s) available for mizoribine and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
Topics: Abatacept; Adjuvants, Immunologic; Calcineurin Inhibitors; Everolimus; Glomerulonephritis; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Levamisole; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Podocytes; Ribonucleosides; Rituximab; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases | 2018 |
[Secondary membranous nephropathy: The topics of membranous lupus nephritis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Calcineurin Inhibitors; Drug Therapy, Combination; Fluorouracil; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Lupus Nephritis; Mitomycin; Prognosis; Ribonucleosides; Semustine; Tacrolimus | 2011 |
[Guidelines for the management of refractory nephrotic syndrome--from investigations between 1997 and 2001--research project team for progressive renal lesions in the Ministry of Health, Labor and Welfare, Japan].
Topics: Blood Component Removal; Cause of Death; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Japan; Nephrotic Syndrome; Practice Guidelines as Topic; Prednisolone; Prognosis; Ribonucleosides; Surveys and Questionnaires; Time Factors | 2002 |
4 trial(s) available for mizoribine and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Efficacy of mizoribine followed by low-dose prednisone in patients with idiopathic membranous nephropathy and nephrotic-range proteinuria.
Topics: Adult; Aged; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Prednisone; Proteinuria; Remission Induction; Ribonucleosides; Severity of Illness Index; Treatment Outcome | 2013 |
Treatment of membranous nephropathy with mizoribine: A control trial.
Topics: Adult; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Ribonucleosides | 2016 |
A randomized open-label comparative study of conventional therapy versus mizoribine onlay therapy in patients with steroid-resistant nephrotic syndrome (postmarketing survey).
Topics: Adult; Drug Resistance; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrotic Syndrome; Patient Dropouts; Product Surveillance, Postmarketing; Proteinuria; Remission Induction; Ribonucleosides; Steroids | 2004 |
Effective treatment of idiopathic membranous nephropathy.
Topics: Aged; Anti-Inflammatory Agents; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Middle Aged; Prednisone; Ribonucleosides | 2000 |
9 other study(ies) available for mizoribine and Glomerulonephritis, Membranous
| Article | Year |
|---|---|
Fanconi syndrome in an elderly patient with membranous nephropathy during treatment with the immunosuppressant mizoribine.
Topics: Acidosis, Renal Tubular; Aged; Aged, 80 and over; Fanconi Syndrome; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Ribonucleosides | 2023 |
Mizoribine combined with steroids and dietary sodium restriction on the treatment of primary membranous nephropathy: a prospective study.
Topics: Cyclophosphamide; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prospective Studies; Ribonucleosides; Sodium; Sodium Chloride, Dietary; Sodium, Dietary; Steroids; Treatment Outcome | 2023 |
Effect of mizoribine pulse therapy in adult membranous nephropathy.
Topics: Adult; Female; Glomerulonephritis, Membranous; Humans; Male; Middle Aged; Ribonucleosides; Treatment Outcome | 2021 |
Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Topics: Aged; Aged, 80 and over; Biopsy; Creatinine; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Glomerulonephritis; Glomerulonephritis, Membranoproliferative; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Male; Methylprednisolone; Mycophenolic Acid; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Proteinuria; Recurrence; Registries; Retrospective Studies; Ribonucleosides; Treatment Outcome | 2015 |
Study of mizoribine therapy in elderly patients with membranous nephropathy: comparison with patients not receiving mizoribine.
Topics: Aged; Anti-Inflammatory Agents; Creatinine; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Prednisolone; Proteinuria; Retrospective Studies; Ribonucleosides | 2015 |
Therapeutic effect of mizoribine on bullous pemphigoid associated with membranous nephropathy.
Topics: Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Middle Aged; Pemphigoid, Bullous; Ribonucleosides | 2009 |
Anti-proteinuric effect of mizoribine monotherapy in three patients with membranous nephropathy.
Topics: Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Middle Aged; Proteinuria; Ribonucleosides | 2010 |
Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases.
Topics: Aged; Female; Glomerulonephritis, Membranous; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Lamivudine; Male; Prednisolone; Ribonucleosides; Treatment Outcome | 2011 |
Changing mizoribine administration from three divided doses to one single dose induced remission of relapsed membranous nephropathy.
Topics: Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Prednisolone; Proteinuria; Recurrence; Remission Induction; Ribonucleosides | 2006 |